However, we can not exclude the possibility that 11q13 amplification plays a role in Ano1 overexpression in PR-positive tumors, since 11q13 has been identified as a susceptibility locus for ER- and PR-positive breast cancer [46]. Here, ANO1 is linked to breast carcinoma.